Neutralization of Acidic Tumor Microenvironment (TME) with Daily Oral Dosing of Sodium Potassium Citrate (K/Na Citrate) Increases Therapeutic Effect of Anti-cancer Agent in Pancreatic Cancer Xenograft Mice Model

Biol Pharm Bull. 2021;44(2):266-270. doi: 10.1248/bpb.b20-00825.

Abstract

Extracellular pH (pHe) of tumor cells is characteristic of tumor microenvironment (TME). Acidic TME impairs the responses of tumors to some anti-cancer chemotherapies. In this study, we showed that daily oral dosing of sodium potassium citrate (K/Na citrate) increased blood HCO3- concentrations, corresponding to increase of HCO3- concentrations and pHs in urine, and neutralized the tumor pHe. Neutralization of acidic TME by alkaline substance like HCO3-, an active metabolite of K/Na citrate, well potentiated the therapeutic effect of anticancer agent TS-1®, an orally active 5-fuluoro-uracil derivative, in Panc-1 pancreatic cancer-xenograft murine model. Neutralization of acidic TME by using an alkaline K/Na citrate is a smart approach for enhancement of the therapeutic effects of anticancer agents for pancreatic cancer in the end stage.

Keywords: acidic extracellular pH; cancer chemotherapy; pancreatic cancer; sodium potassium citrate; tumor microenvironment (TME).

MeSH terms

  • Administration, Oral
  • Animals
  • Antacids / administration & dosage*
  • Antacids / pharmacokinetics
  • Cell Line, Tumor
  • Drug Combinations
  • Drug Synergism
  • Extracellular Space / chemistry
  • Extracellular Space / drug effects
  • Female
  • Humans
  • Hydrogen-Ion Concentration / drug effects*
  • Mice
  • Oxonic Acid / administration & dosage*
  • Oxonic Acid / pharmacokinetics
  • Oxonic Acid / therapeutic use
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / pathology
  • Potassium Citrate / administration & dosage
  • Potassium Citrate / pharmacokinetics
  • Sodium Citrate / administration & dosage
  • Sodium Citrate / pharmacokinetics
  • Tegafur / administration & dosage*
  • Tegafur / pharmacokinetics
  • Tegafur / therapeutic use
  • Tumor Microenvironment / drug effects*
  • Xenograft Model Antitumor Assays

Substances

  • Antacids
  • Drug Combinations
  • S 1 (combination)
  • Tegafur
  • Sodium Citrate
  • Oxonic Acid
  • Potassium Citrate